You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in Brazil

May 2012

Price: US$900

About this Report

About this Report

Samples (FAQs about samples):

doc_pdf.png Sample Cough, Cold and Allergy (Hay Fever) Remedies Market Research Report

doc_excel_table.png Sample Cough, Cold and Allergy (Hay Fever) Remedies Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Brazil with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Brazil, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Brazil market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Brazil?
  • What are the major brands in Brazil?
  • What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

TRENDS

  • Higher income levels amongst the poorer segments of society drove sales of cough, cold and allergy (hay fever) remedies in Brazil in 2011. Not only did higher incomes mean more discretionary income to spend on healthcare, but also improved economic conditions allowed less privileged consumer groups to gain access to healthcare providers, as well as to gain more information about the medicines available and product characteristics.

COMPETITIVE LANDSCAPE

  • Medicated confectionery accounted for a 31% share of overall value sales of cough, cold and allergy (hay fever) remedies in Brazil in 2011. Manufacturers tend to target young consumer groups, positioning their brands as flavoursome, refreshing and able to alleviate the minor discomforts of colds and coughs. Cadbury Adams Brasil Indústria e Comércio de Produtos Alimentícios led cough, cold and allergy (hay fever) remedies in 2011 with a 12% value share with the brand Halls, which accounted for a 10% value share. Its lead can be attributed to the wide presence of Halls in mass media channels, as well as in social media networks. Targeting young consumer groups, Halls invests in sweepstakes and digital campaigns. In 2011 30% of the brand’s marketing budget was allocated to the campaign for Halls Mel Mix, which positions the brand as flavoursome and refreshing. Besides Halls, other brands of medicated confectionery, such as Icekiss and Freegells, enjoy popularity, with each brand holding a 3% value share in 2011.

PROSPECTS

  • Cough, cold and allergy (hay fever) remedies is expected to see a CAGR of 5% in constant value terms during the forecast period. Rising living standards will contribute to higher sales of such products. Improved economic conditions are expected to continue, allowing the lower-income urban populations to purchase cold and cough remedies which help to alleviate the respiratory problems caused by pollution and viral contamination. Higher employment will continue to expose a larger number of individuals, who use public transportation, to the propagation of cold and flu viruses.

Table of Contents

Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in Brazil - Category Analysis

HEADLINES

TRENDS

  • Higher income levels amongst the poorer segments of society drove sales of cough, cold and allergy (hay fever) remedies in Brazil in 2011. Not only did higher incomes mean more discretionary income to spend on healthcare, but also improved economic conditions allowed less privileged consumer groups to gain access to healthcare providers, as well as to gain more information about the medicines available and product characteristics.

SWITCHES

COMPETITIVE LANDSCAPE

  • Medicated confectionery accounted for a 31% share of overall value sales of cough, cold and allergy (hay fever) remedies in Brazil in 2011. Manufacturers tend to target young consumer groups, positioning their brands as flavoursome, refreshing and able to alleviate the minor discomforts of colds and coughs. Cadbury Adams Brasil Indústria e Comércio de Produtos Alimentícios led cough, cold and allergy (hay fever) remedies in 2011 with a 12% value share with the brand Halls, which accounted for a 10% value share. Its lead can be attributed to the wide presence of Halls in mass media channels, as well as in social media networks. Targeting young consumer groups, Halls invests in sweepstakes and digital campaigns. In 2011 30% of the brand’s marketing budget was allocated to the campaign for Halls Mel Mix, which positions the brand as flavoursome and refreshing. Besides Halls, other brands of medicated confectionery, such as Icekiss and Freegells, enjoy popularity, with each brand holding a 3% value share in 2011.

PROSPECTS

  • Cough, cold and allergy (hay fever) remedies is expected to see a CAGR of 5% in constant value terms during the forecast period. Rising living standards will contribute to higher sales of such products. Improved economic conditions are expected to continue, allowing the lower-income urban populations to purchase cold and cough remedies which help to alleviate the respiratory problems caused by pollution and viral contamination. Higher employment will continue to expose a larger number of individuals, who use public transportation, to the propagation of cold and flu viruses.

CATEGORY DATA

  • Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 3 Sales of Decongestants by Category: Value 2006-2011
  • Table 4 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 5 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 6 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 7 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 8 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 9 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 10 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Brazil - Company Profiles

Aché Laboratórios Farmacêuticos SA in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 3 Aché Laboratórios Farmacêuticos SA: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 4 Aché Laboratórios Farmacêuticos SA: Competitive Position 2011

Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 6 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 7 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2011

Cadbury Adams Brasil Indústria e Comércio de Produtos Alimentícios Ltda in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 Cadbury Adams Indústria e Comércio Alimentícios Ltda: Competitive Position 2011

EMS SA in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 12 EMS SA: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 13 EMS SA: Competitive Position 2011

Eurofarma Laboratório Ltda in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 16 Eurofarma Laboratório Ltda: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 17 Eurofarma Laboratório Ltda: Competitive Position 2011

Hypermarcas SA in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 20 Hypermarcas SA: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 21 Hypermarcas SA: Competitive Position 2011

Medley SA Indústria Farmacêutica in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 24 Medley SA Indústria Farmacêutica: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 25 Medley SA Indústria Farmacêutica: Competitive Position 2011

Nycomed Pharma Ltda in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 28 Nycomed Pharma Ltda: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 29 Nycomed Pharma Ltda: Competitive Position 2011

Sanofi-Aventis Farmacêutica Ltda in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 32 Sanofi-Aventis Farmacêutica Ltda: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 33 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2011

Consumer Health in Brazil - Industry Context

EXECUTIVE SUMMARY

Consumer health continues to show double-digit growth

Back to basics: non-prescription drugs are expected to return to OTC status

Acquisitions are expected to continue as market growth attracts investors

Mergers and acquisitions in parapharmacies/drugstores

A domestic pharmaceutical company is created to produce biotechnological drugs

KEY TRENDS AND DEVELOPMENTS

ANVISA is expected to change the rules for sales of non-prescription drugs

Vitamins and dietary supplements suffers from deficient regulation

Price control tools keep adjustments below inflation, but are not sufficient

Market growth drives company activity

Domestic companies join forces to produce biotechnological remedies

MARKET INDICATORS

  • Table 11 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 12 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 13 Sales of Consumer Health by Category: Value 2006-2011
  • Table 14 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 15 Consumer Health Company Shares 2007-2011
  • Table 16 Consumer Health Brand Shares 2008-2011
  • Table 17 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 18 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 19 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 20 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

De-reimbursement

Generics

Advertising

Packaging and Labelling

Distribution

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

SOURCES

  • Summary 34 Research Sources

Segmentation

Segmentation

This market research report includes the following:

  • Cough, Cold and Allergy (Hay Fever) Remedies

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!